Aim. To investigate the association between premature ovarian insufficiency (POI) and the development of metabolic syndrome in women. Design. A single-center, cross-sectional comparative study. Materials and methods. The study included 80 women divided into three groups: Group 1 (control, n = 39) — women with regular menstrual cycles and normal levels of follicle-stimulating hormone (FSH) and estradiol; Group 2 (n = 24) — women with amenorrhea lasting 3–12 months and elevated FSH > 25 IU/L (POI); Group 3 (n = 17) — women with amenorrhea lasting > 12 months and persistently elevated FSH (premature menopause, PM). Anthropometric parameters, blood pressure, and laboratory markers of carbohydrate and lipid metabolism were analyzed. Results. Women with estrogen deficiency (Groups 2 and 3) exhibited significantly higher body mass index, waist circumference, systolic and diastolic blood pressure, and adverse changes in lipid profile, including decreased high-density lipoprotein, elevated low-density lipoprotein, and triglycerides. Additionally, a considerable proportion of PM patients showed impaired fasting glucose, indicating a high risk of insulin resistance and type 2 diabetes. The prevalence of metabolic syndrome (based on IDF criteria) was 47.6% in the POI group and 52.9% in the PM group. Conclusion. Premature ovarian insufficiency and premature menopause are associated with significant metabolic disturbances, including abdominal obesity, hypertension, dyslipidemia, and impaired glucose metabolism. These conditions represent independent risk factors for metabolic syndrome in young women. Early diagnosis and prevention of metabolic complications in this patient population are of crucial clinical importance. Large-scale multicenter studies are needed to validate these findings. Keywords: premature ovarian insufficiency, premature menopause, metabolic syndrome, abdominal obesity, hypoestrogenism.